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A
 
Dynamic View of T Cell Behavior
 
. For many years it has
been known that T lymphocytes engage APCs in a
long-lasting interaction that results in the generation of a
rapid and sustained signal in T cells. Lasting almost 1 h, this
sustained signal is required by T cells to maintain the tran-
scription factors translocated in the nucleus and, ultimately,
to become activated (1). However, in view of the low
number of ligands recognized and of the low affinity of
TCR, the question of how T cells maintain the sustained
signal and become activated remained a puzzle (2).
Unlike the antigen–antibody interaction that can be eas-
ily studied by measuring the proportions of the reactants at
equilibrium, the interaction of the TCR with its ligand has
proved to be much more difficult to analyze. This interac-
tion occurs in the limited space between the opposing mem-
 
branes of two motile cells, the T cell carrying 
 
z
 
30,000
TCRs and the APC displaying few ligands, typically 
 
z
 
100
complexes for recognition by T helper cells (3, 4) and per-
haps as few as one complex for recognition by cytotoxic T
cells (5).
Because of the small number of ligands recognized, it
was originally thought that only few TCRs would be en-
gaged and would be sufficient to initiate and sustain the sig-
nal transduction cascade for the time necessary to lead to T
cell activation. In other words, it was thought that, once
the appropriate molecular interactions had been set in place,
the signal would be self sustained. In the last three years a
kinetic and stoichiometric analysis of the TCR-peptide–
MHC interaction has revealed a very dynamic type of in-
teraction.
Two experimental approaches have proved particularly
useful for studying the dynamics of TCR-peptide–MHC
interaction in living cells. The first is the continuous moni-
toring of the TCR-mediated signaling that can be achieved
by measuring intracellular calcium elevations or medium
acidification. These methods have been used to demon-
strate that the sustained signal in T cell–APC conjugates re-
quires a continuous engagement of TCRs with peptide–
MHC complexes on APC. Indeed, treatments that prevent
these continuous engagements such as addition of anti-MHC
antibodies, blocking of the actin cytoskeleton, or removal
of peptide antigen, can terminate the signaling process within
2–4 min, demonstrating that the signal emanating from
triggered TCR is short lived (6, 7).
The second approach is the measurement of the stoichi-
ometry of the TCR–ligand interaction. Valitutti et al. have
shown that TCR downregulation is a reliable readout of
the number of TCRs triggered. Using this method it was
shown that, over time, as many as 20,000 TCRs are trig-
gered by as few as 100 peptide–MHC complexes (8). Thus
the fast kinetics of TCR–ligand interaction appears to be a
key feature allowing multiple TCR engagements by a sin-
gle agonist (for review see reference 9). In addition, T cells
appear to be able to take a “count” of the number of TCRs
triggered and respond by proliferation and cytokine pro-
duction when an activation threshold is reached (10).
Three papers in 
 
The Journal of Experimental Medicine
 
 have
used these methods to reveal new aspects of TCR signaling
induced by peptide–MHC complexes with agonistic or an-
tagonistic properties and by APC with different costimula-
tory capacities.
 
Sustained Signaling Inhibited by TCR Antagonists.
 
The paper by
Wülfing et al. (11) analyzes the calcium signal at single cell
level in T cells activated by a variety of ligands alone or in
combination. The authors distinguish four patterns of in-
tracellular calcium elevation. Although agonist induced a
robust response that correlated with T cell proliferation, three
antagonist complexes gave very different release patterns,
or none at all. In addition, when added together with the
agonist, the antagonists markedly reduced the calcium re-
sponse. These results demonstrate that antagonism does not
require calcium release, but can inhibit the calcium signal
triggered by agonists. Interestingly, the authors report an
inverse correlation between the strength of the stimulus
and the time required for the onset of the calcium signal af-
ter T-APC contact. The dose dependence of this delay has
been interpreted to indicate that the rate-limiting step in
the calcium response involves accumulation of some form
of intracellular complex or molecule with a half-life of a
few minutes.
The paper by Preckel et al. (12) reports that class I–restricted
CTL specific for haptenated peptides can be antagonized
by ligands carrying subtle differences in either the hapten
or the peptide. Interestingly, although agonists induced a
dose-dependent downregulation of TCR, antagonists failed
to do so, despite engaging the specific TCR. Moreover,
when offered together, the antagonist inhibited TCR down-
regulation induced by agonists. In this system, no sign of
anergy or receptor inactivation was evident. Instead, these
results suggest that antagonists block T cell functions by
competitively engaging the specific TCR in unproductive
interactions that do not result in downregulation, nor in in-
activation or anergy.
Taken together, these two papers make an important
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contribution to understanding TCR antagonism (13–15).
They demonstrate that antagonists not only fail to induce a
calcium signal as well as TCR downregulation, but also,
and more importantly, inhibit calcium signal and downreg-
ulation induced by agonists. These results are compatible
with the notion that sustained signaling requires a mini-
mum rate of TCR triggering to produce sufficient concen-
trations of second messengers. It appears that, either be-
cause of their higher concentration or because of their faster
kinetics (16), antagonists can rapidly engage, in a nonpro-
ductive fashion, a large number of TCRs, thus leaving only
a few available for triggering by agonists. In this way, the
antagonists decrease the rate of TCR triggering below that
sufficient for sustaining the signal. Indeed, previous work
has shown that reduction in the number of TCRs has a
dramatic effect on the capacity of T cells to respond to low
concentrations of agonist and to sustain the signaling pro-
cess (10).
 
TCR Occupancy and T Cell Activation.
 
A third paper by Cai
et al. (17) investigates the requirements for TCR downreg-
ulation and T cell activation in naive CD8
 
1
 
 T cells using
peptide–MHC complexes of different affinities for the TCR.
The APCs used by the authors are 
 
Drosophila
 
 cells, engi-
neered to express extremely high levels of a single peptide–
MHC complex in the total absence or in the presence of
adhesion and costimulatory molecules. Using these ex-
treme experimental conditions, TCR downregulation can
be dissociated from T cell activation. The authors show that
when costimulatory APCs are used, T cell activation can
occur in the absence of measurable TCR downregulation,
whereas with APCs that display the agonist in the absence
of adhesion and costimulatory molecules, no activation is
observed in spite of an almost complete TCR downregula-
tion. The fact that the authors do not find a correlation be-
tween the extent of TCR downregulation and T cell acti-
vation is not entirely surprising. Indeed, it is well known
that the final outcome of TCR triggering (signal 1 as mea-
sured by TCR downregulation) is modulated by additional
stimuli provided by costimulation (signal 2) (18). In a pre-
vious study done on human T cells, it was shown that in
the absence of costimulation, a relatively large number of
TCR have to be triggered (
 
z
 
8,000) to activate a T cell,
whereas this threshold is decreased to 
 
z
 
1,500 if costimula-
tion is provided (10).
The findings by Cai et al. are also important for our un-
derstanding of the nature of the ligands that induce TCR
downregulation, as well as for the mechanism of downreg-
ulation itself. As to the first point, all the data reported so
far indicate a good correlation between the capacity of a
ligand to induce TCR downregulation, and its strength as
an agonist (8, 10, 12, 17). Indeed, weak agonists have a
lower capacity to downregulate TCR that exactly reflect
their reduced capacity to induce calcium signal and to acti-
vate T cells to produce cytokines, while antagonists fail to
do so. As to the mechanism, Cai et al. show that TCR
downregulation is not inhibited by genistein or azide. Fur-
ther evidence indicates that TCR downregulation is also
resistant to inhibitors or depletion of protein tyrosine kinases
and results from targeting and degradation of TCRs in the
lysosomes (19).
 
From Serial Engagements to T Cell Activation.
 
The sustained sig-
naling in T-APC conjugates appears to be maintained by a
very dynamic mechanism (Fig. 1). The fast kinetics of in-
teraction allows a single peptide–MHC complex to engage
many TCRs over time. The fate of these engagements can
vary depending on the stability of the interaction which
can be influenced by the presence of a coreceptor. Engage-
ments that are stable enough result in complete assembly of
the signal transduction machinery and triggering of the
TCR. This leads to the production of second messengers
that accumulate to the point where a calcium signal is re-
leased. However, these messengers are short lived and, in
the absence of a continuous TCR triggering, the signal will
stop. This happens experimentally when we interfere with
TCR–agonist interaction or spontaneously as a consequence
of TCR downregulation (20). By serially engaging and
triggering TCRs, few agonists can maintain sufficient levels
of second messengers to sustain the signal.
How can antagonists interfere with serial triggering by
agonists? Because of their fast kinetics (16), antagonists can
engage TCRs very efficiently. However, although we can-
not exclude the possibility of a transient inactivation of
some substrates of the signal transduction cascade, it seems
Figure 1. From serial engagements to T cell activation. In the area of
contact between T and APC, few ligands serially engage TCRs. The du-
ration of the interaction determines whether the TCR is triggered or not.
Strong agonists are efficient at serially triggering TCRs, whereas antago-
nists fail to trigger and spoil many TCRs, thus effectively competing with
agonists. Once triggered, the TCRs generate labile second messengers
and signal for a short time until they are eventually degraded in lysosomes,
whereas new TCRs are recruited in the contact area. When a sufficient
concentration of second messengers is reached, the calcium signal is re-
leased. This signal is sustained so long as a minimum rate of TCR trigger-
ing is maintained. The sustained signaling is required for induction of
transcription of cytokine genes, resulting in T cell activation. Costimula-
tory signals generated in the area of contact can modulate the outcome of
those emanating from the TCR and effectively decrease the number of
TCR-triggering events required to induce T cell activation. 
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that challenge with antagonists per se does not lead to any
form of signal transduced, neither is there any long- or
short-term consequence on T cells. The serial spoiling of
TCRs by antagonists could be the basis for their capacity to
effectively reduce the rate of triggering by agonists.
How do we go from serial engagement to T cell activa-
tion? The possibility of measuring signal 1 using TCR
downregulation has provided a quantitative framework to
the notion that the effect of the signals emanating from
TCRs can be influenced by signals delivered by costimula-
tory molecules (18). Clearly, the level of TCR engagement
required to trigger a T cell is very high in the absence, and
much lower in the presence, of costimulation. Understand-
ing the nature of the costimulatory signals and how they
are integrated those from TCR will be a major task for fu-
ture research.
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